1. Redemsivir approval 2. Another VIP company closing shop on A VIP drug trial .
To lesser knowledgeable investors this PhaseBio's Vip derivative is the same as RLFTF, but it isn't. And apparently the form isn't nuetralizing COVID or it's form is fine but SUBQ delivery isn't a viable delivery for the hormone?
Because we have picked up PLENTY of new investors along the way who have not done their DD and just bought on the hopes of a pop based on something someone told them or something they read. This is obvious if you look at all the confusion on YHoo board. And because those people do not know the company and situation well enough, they panic very easily. They will be back in buying mode once the dust settles and their emotions swing to the other direction.
P.S. This is why I have spent time putting together resources for new investors... to at least raise their level of knowledge a bit, so we can dampen some of the ridiculous wild swings. Please feel free to reuse my posts in any way you see fit.
Market Data 
Markets 
AI
